AFP and hepatocellular carcinoma: In differentiating AFP-negative HCC from the HCC risk population (CHB and LC) in cohort B, once again, a similar AUC (0.834, 95% CI 0.779–0.891, sensitivity: 63.2%, specificity: 90.7%, Fig 5D) was revealed.